Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Laterra

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Cancer Research|February 3, 2012
Cancer stem cells: distinct entities or dynamically regulated phenotypes?Yunqing Li, John Laterra
Neuro-Oncology|October 11, 2005
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisRoger Abounader, John Laterra
Biochemical and Biophysical Research Communications|May 30, 2006
Hepatocyte growth factor increases mitochondrial mass in glioblastoma cellsShuli Xia, John Laterra
Expert Opinion on Investigational Drugs|March 21, 2007
Emerging monoclonal antibody therapies for malignant gliomasDavid E Gerber, John Laterra
Molecular & Cellular Oncology|June 17, 2016
The cancer stem cell phenotype: You can't win until you learn how to lose itHernando Lopez-Bertoni, John Laterra
Translational Oncology|March 15, 2021
Opinion: miRNAs - The new wave of molecular cancer therapeuticsHernando Lopez-Bertoni, John Laterra
Neoplasia (New York, N.Y.)|December 25, 2008
Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/PgpYimao Zhang, John Laterra, Martin G Pomper
Cancer Research|June 17, 2005
Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stressShuli Xia, Eliot M Rosen, John Laterra
Expert Opinion on Investigational Drugs|May 13, 2016
Investigational new drugs for brain cancerVerena Staedtke, Ren-Yuan Bai, John Laterra
Biology and Medicine (Aligarh)|May 10, 2016
Cancer Stem Cells: Dynamic Entities in an Ever-Evolving ParadigmHernando Lopez-Bertoni, Yunqing Li, John Laterra
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Cancer Research|February 3, 2012
Cancer stem cells: distinct entities or dynamically regulated phenotypes?Yunqing Li, John Laterra
Neuro-Oncology|October 11, 2005
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisRoger Abounader, John Laterra
Biochemical and Biophysical Research Communications|May 30, 2006
Hepatocyte growth factor increases mitochondrial mass in glioblastoma cellsShuli Xia, John Laterra
Expert Opinion on Investigational Drugs|March 21, 2007
Emerging monoclonal antibody therapies for malignant gliomasDavid E Gerber, John Laterra
Molecular & Cellular Oncology|June 17, 2016
The cancer stem cell phenotype: You can't win until you learn how to lose itHernando Lopez-Bertoni, John Laterra
Translational Oncology|March 15, 2021
Opinion: miRNAs - The new wave of molecular cancer therapeuticsHernando Lopez-Bertoni, John Laterra
Neoplasia (New York, N.Y.)|December 25, 2008
Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/PgpYimao Zhang, John Laterra, Martin G Pomper
Cancer Research|June 17, 2005
Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stressShuli Xia, Eliot M Rosen, John Laterra
Expert Opinion on Investigational Drugs|May 13, 2016
Investigational new drugs for brain cancerVerena Staedtke, Ren-Yuan Bai, John Laterra
Biology and Medicine (Aligarh)|May 10, 2016
Cancer Stem Cells: Dynamic Entities in an Ever-Evolving ParadigmHernando Lopez-Bertoni, Yunqing Li, John Laterra
Pageof 13